Terrence F Blaschke
Overview
Explore the profile of Terrence F Blaschke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
688
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gholizadeh S, Exuzides A, Sinnott J, Palmer C, Waltz M, Rose J, et al.
Sci Rep
. 2024 Oct;
14(1):26150.
PMID: 39477975
Neuromyelitis optica spectrum disorders (NMOSD) comprise autoimmune diseases imposing substantial disability. We compared an NMOSD-targeted disability assessment of mobility, vision, and self-care domains (individually and composite) with the multiple sclerosis-targeted...
2.
Meyer U, Amara S, Blaschke T, Insel P
Annu Rev Pharmacol Toxicol
. 2023 Oct;
64:27-31.
PMID: 37816308
The reviews in Volume 64 of the cover diverse topics. A common theme in many of the reviews is the interindividual variability in the clinical response to drugs. Highlighted areas...
3.
Gholizadeh S, Exuzides A, Lewis K, Palmer C, Waltz M, Rose J, et al.
J Neurol
. 2022 Dec;
270(4):2048-2058.
PMID: 36565348
Objective: Neuromyelitis optica spectrum disorders (NMOSD) represent rare autoimmune diseases of the central nervous system largely targeting optic nerve(s) and spinal cord. The present analysis used real-world data to identify...
4.
Browne S, Vaida F, Umlauf A, Tucker A, Blaschke T, Benson C
Clin Infect Dis
. 2022 Dec;
76(1):134-143.
PMID: 36484300
Background: Timely, accurate adherence data may support oral pre-exposure prophylaxis (PrEP) success and inform prophylaxis choice. We evaluated a Food and Drug Administration (FDA)-approved digital health feedback system (DHFS) with...
5.
Blaschke T, Insel P, Amara S, Meyer U
Annu Rev Pharmacol Toxicol
. 2022 Oct;
63:15-18.
PMID: 36270297
Investigations in pharmacology and toxicology range from molecular studies to clinical care. Studies in basic and clinical pharmacology and in preclinical and clinical toxicology are all essential in bringing new...
6.
Insel P, Blaschke T, Amara S, Meyer U
Annu Rev Pharmacol Toxicol
. 2021 Oct;
62:19-24.
PMID: 34606327
The reviews in Volume 62 of the () cover a diverse range of topics. A theme that encompasses many of these reviews is their relevance to common diseases and disorders,...
7.
Costa M, Blaschke T, Amara S, Meyer U, Insel P
Annu Rev Pharmacol Toxicol
. 2021 Jan;
61:1-7.
PMID: 33411582
The theme of Volume 61 is "Old and New Toxicology: Interfaces with Pharmacology." Old toxicology is exemplified by the authors of the autobiographical articles: B.M. Olivera's work on toxins and...
8.
Boffito M, Back D, Flexner C, Sjo P, Blaschke T, Horby P, et al.
Clin Pharmacol Ther
. 2020 Oct;
110(1):64-68.
PMID: 33113246
The urgent global public health need presented by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) has brought scientists from diverse backgrounds together in an unprecedented international effort to rapidly identify interventions....
9.
Wilson J, Cheung K, Lin L, Green E, Porras A, Zou L, et al.
Sci Transl Med
. 2020 Jul;
12(554).
PMID: 32727913
Requiring regional or in-country confirmatory clinical trials before approval of drugs already approved elsewhere delays access to medicines in low- and middle-income countries and raises drug costs. Here, we discuss...
10.
Dolphin A, Insel P, Blaschke T, Meyer U
Annu Rev Pharmacol Toxicol
. 2020 Jan;
60:1-6.
PMID: 31914892
"Ion Channels and Neuropharmacology: From the Past to the Future" is the main theme of articles in Volume 60 of the . Reviews in this volume discuss a wide spectrum...